Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention (MONITOR Study)

NCT06750731 is registered in ClinicalTrials.gov with Mercy Medical Center as lead sponsor.

NCT NCT06750731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06750731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention (MONITOR Study)
Lead sponsor
Mercy Medical Center
Phase
Observational
Overall status
Recruiting
Start date
May 5, 2025
Completion date
September 30, 2027
Enrollment
200 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, inflammatory bowel disease (ibd), ulcerative colitis